Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating an update to the page's version of the study record.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedUpdates the displayed ClinicalTrials.gov page revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Ono Pharmaceutical Co., Ltd. and Revision: v3.5.2; removed Ono Pharmaceutical Co. Ltd and Revision: v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedLocation entry for Italy 35128 updated from Padua to Padova. Padova, Italy, 35128 is now listed as a site.SummaryDifference0.0%

- Check73 days agoChange DetectedUpdated the location from Napoli, Italy, 80131 to Naples, Italy, 80131. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3; a minor template update with no changes to study details or data.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.